Delivery Order SPE2DB20D9127-SPE2DB23FPRU8

Award Date 9/26/23
Potential Completion Date 10/18/23
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999. The contract is for the delivery of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the supply of the medication Mirena 52 mg systems to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The award has a ceiling value of $17,760.00 and is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of Mirena 52 mg systems. The $2,368.00 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under the SPE2DB program, which is a $499,999,999 Indefinite Delivery Contract (IDC) that allows the DLA to issue delivery orders for a wide range of pharmaceutical products and medical supplies to support the medical needs of military...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $8,880.00, is for the delivery of the Mirena 52 mg contraceptive system. DMS Pharmaceutical Group has a significant $499,999,999 indefinite delivery contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $2,960.00 for the supply of Mirena 52 mg systems. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not associated with a set-aside designation. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the provision of Mirena 52 mg systems. The $1,184 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) under the agency's Medical Supply Chain program. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that supplies a wide range of medications, including branded and generic prescription drugs, over-the-counter products, biologics, and medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order under the SPE2DB program. The $2,603.85 award is for the delivery of Mirena 52 mg contraceptive systems to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to issue delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a Delivery Order worth $1,776.00 under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC) program. The contract is for the delivery of Mirena 52 mg systems, a contraceptive device, to support the medical supply needs of military healthcare facilities. The award has a firm fixed-price pricing type and an ultimate completion date of December 16, 2024....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a Delivery Order (DO) valued at $1,776.00 under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC) program. The IDC, worth up to $499,999,999, allows the DLA to issue firm fixed-price DOs to DMS Pharmaceutical for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $7,696.00 firm fixed-price delivery order is for the supply of Mirena 52 mg systems, a contraceptive product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, which allows the agency to issue delivery orders for a...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB23FPRU8
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $1,161.94 firm fixed-price delivery order is for the supply of specialized pharmaceutical products, including the Mirena 52 mg system. This award is not associated with any set-aside designation.

DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA through its federal contract awards.

Generated 2/27/25, 12:26 PM